Artificial extracellular matrix proteins contain heparin-binding and RGD-containing domains to improve osteoblast-like cell attachment and growth

Journal of Biomedical Materials Research - Part A

Volumn 79, Issue 3, 2006, Pages 557-565

  Wu, Suh Chin ^a   Yu, Jung Chuan ^a   Hsu, Shan Hui ^b   Chen, David Chanhen ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Extracellular matrix protein; Heparin binding domain; Osteoblast tissue engineering; Polycaprolactone; RGD

Indexed keywords

CELL CULTURE; CELLS; ESCHERICHIA COLI; GROWTH KINETICS;

EXTRACELLULAR MATRIX PROTEIN; HEPARIN; OSTEOBLAST TISSUE ENGINEERING; POLYCAPROLACTONE;

PROTEINS;

ARGINYLGLYCYLASPARTIC ACID; HEPARIN BINDING PROTEIN; POLYCAPROLACTONE; RECOMBINANT PROTEIN; SCLEROPROTEIN;

ARTICLE; CELL ADHESION; CELL GROWTH; CONTROLLED STUDY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OSTEOBLAST; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; TISSUE CULTURE; TISSUE ENGINEERING;

AMINO ACID SEQUENCE; BINDING SITES; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HEPARIN; HUMANS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; OSTEOBLASTS;

EID: 33751560268     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30845     Document Type: Article

References (35)

1. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003;24:4353-4364.
2. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004;428:487-492.
3. Kurihara U, Morita T, Shinkai M, Nagamune T. Recombinant extracellular matrix-like proteins with repetitive elastin or collagen-like functional motifs. Biotechnol Lett 2005;27:665-670.
4. Heilshorn SC, DiZio KA, Welsh ER, Tirrell DA. Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins. Biomaterials 2003;24:4245-4252.
5. Liu JC, Heilshorn SC, Tirrell DA. Comparative cell response to artificial extracellular matrix proteins containing the RGD and CS5 cell-binding domains. Biomacromolecules 2004;5:497-504.
6. Culter SM, Garcia AJ. Engineering cell adhesive surfaces that direct a5b1 binding using a recombinant fragment of fibronectin. Biomaterials 2003;24:1759-1770.
7. Jang JH, Hwang JH, Chung CP. Production of recombinant tenascin-C module containing a cell adhesive recognition motif of RGD. Biotechnol Lett 2004;26:1831-1835.
8. Wu SC, Chiang JR, Lin CW. Novel cell adhesive glycosaminoglycan-binding proteins of Japanese encephalitis virus. Biomacromolecules 2004;5:2160-2164.
9. Aubin JE. Bone stem cells. J Cell Biochem Suppl 1998;30/31:73-82.
10. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 1994;9:487-496.
11. Wiesmann HP, Joos U, Meyer U. Biological and biophysical principles in extracorporal bone tissue engineering, Part 2. Int J Oral Maxillofac Surg 2004;33:523-530.
12. Howard GA, Turner RT, Puzas JE, Nichols F, Baylink DJ. Bone cells on microcarrier spheres. JAMA 1983;249:258,259.
13. Qiu Q, Ducheynu P, Gao H, Ayyaswamy P. Formation and differentiation of three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-wall vessel. Tissue Eng 1998;4:19-34.
14. Radin S, Ducheyne P, Ayyaswamy PS, Gao H. Surface transformation of bioactive glass in bioreactors simulating microgravity conditions, Part 1: Experimental study. Biotechnol Bioeng 2001;75:369-378.
15. Ontiveros C, McCabe LR. Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J Cell Biochem 2003;88:427-437.
16. Declercq HA, Gorski TL, Tielens SP, Schacht EH, Cornelissen MJ. Encapsulation of osteoblast seeded microcarriers into injectable, photopolymerizable three-dimensional scaffolds based on D,L-lactide and ε-caprolactone. Biomacromolecules 2005;6:1608-1614.
17. Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 1994;15:585-591.
18. Sanford KK, Earle WR, Evans VJ, Waltz HK, Shannon JE. The measurement of proliferation in tissue cultures by enumeration of cell nuclei. J Natl Cancer Inst 1951;11:733-795.
19. Lee E, Lobigs M. Substitutions at the putative receptor-binding site of an encephalitis flavivirus alter virulence and host cell tropism and reveal a role for glycosamirtoglycans in entry. J Virol 2000;74:8867-8875.
20. Hurrelbrink RJ, McMinn PC. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelop protein. J Virol 2001;75:7692-7702.
21. 3 intergrin mediates virus entry into cells. J Biol Chem 2004;279:54533-54541.
22. Pierschbacher MD, Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci USA 1984;81:5985-5988.
23. Pytela R, Pierschbacher MO, Ruoslahti E. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985;40:191-198.
24. Pytela R, Pierschbacher MD, Ruoslahti E. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA 1985;82:5766-5770.
25. 1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem 1998;273:11423-11428.
26. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res 1997;37:9-19.
27. Benoit DS, Anseth KS. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 2005;26:5209-5220.
28. Dalton BA, McFarland CD, Underwood PA, Steele JG. Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J Cell Sci 1995;108:2083-2092.
29. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999;15:19-32.
30. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-2543.
31. Cao T, Ho KH, Teoh SH. Scaffold design and in vitro study of osteochondral coculture in three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng 2003;9:103-112.
32. Rai B, Teoh SH, Ho KH, Hutmacher DW, Cao T, Chen F, Yacob K. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 2004;25:5499-5506.
33. Hsu SH, Chu WP, Lin YS, Chiang YL, Chen DC, Tsai CL. The effect of an RGD-containing fusion protein CBD-RGD in promoting cellular adhesion. J Biotechnol 2004;111:143-154.
34. Marletta C, Ciapetti G, Satriano C, Pagani S, Baldini N. The effect of irradiation modification and RGD sequence adsorption on the response of human osteoblasts to polycaprolactone. Biomaterials 2005;26:4793-4804.
35. Kim HW, Lee EJ, Kim HE, Salih V, Knowles JC. Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity. Biomaterials 2005;26:4395-4404.